|
Bringing together transformative imaging technology with advanced breast biopsy capabilities.
The Oslo Tomosynthesis Screening Trial demonstrated that breast cancer screening with Hologic tomosynthesis significantly improves cancer detection, with a 27% increase in overall cancer detection and 40% increase in invasive cancer detection.*
We are excited to announce that tomosynthesis breast biopsy** is now available for the Affirm breast biopsy guidance system, exclusively for use with the Selenia Dimensions tomosynthesis system.
Visit Hologic at NCBC, Booth #100, to see how together, we can make a difference in breast cancer detection, diagnosis and treatment.
|
REGISTER
Exclusive Hologic Event at The 23rd Annual National Interdisciplinary Breast Center Conference
Breakfast Symposium:
An Overview of Clinical Data of Tomosynthesis
Presented by:
Stephen Rose, MD
Founder and Owner
Rose Imaging Specialists
Houston, TX
Dr. Rose will provide an overview of the results of clinical studies in screening and diagnostic applications for 3D mammography as well as demonstrate the positive impact 3D mammography can have on both sensitivity and specificity.
March 25, 2013 | 7:00 am
Vendome Room A-C
 |
* Skaane P. et. al. Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program. Radiology. 2013 Jan 7 [Epub ahead of print].
** Optional software license and Selenia Dimensions tomosynthesis system is required. |
|
|
Hologic, Affirm, Dimensions and Selenia are trademarks and/or registered trademarks of Hologic and/or its subsidiaries in the U.S. and/or other countries. This information is intended for medical professionals in the U.S. and other markets, and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, write to womenshealth@hologic.com.
|
|
|